JTA NEWS
27 May 2019 - 22 Iyyar 5779 - כ"ב אייר ה' אלפים תשע"ט
JTA NEWS :
Chinese healthcare conglomerate Thalys signs MOU with Israel’s iCan E-mail

Thalys Medical Technology, a leading Chinese healthcare conglomerate listed on the Shanghai Stock Exchange, signed a Memorandum of Understanding (MOU) on 11April with iCAN IsraelCannabis, Israel’s leading medical cannabis incubator.

Thalys and iCAN will come together to create a unique partnership to advance the development of early-stage incubated companies that focus on the creation of medical technology, agricultural technology and general intellectual property focusing on the medical hemp industry.

“Thalys and iCAN each bring unique strengths to this partnership, which is strategic in every sense. Thalys will help iCAN’s portfolio companies enter the world’s most populous consumer market. Thalys, which plans to co-invest in iCAN’s portfolio investments that address Chinese market needs, will have exclusive cooperation rights on iCAN’s incubated start-ups and we will have matching stakes in new investments. I am honoured, humbled and proud to work cooperatively with one of China’s leading medical technology companies,” said Saul Kaye, CEO of iCAN.

Please login or register to see the full article
 

Warning: Parameter 1 to modMainMenuHelper::buildXML() expected to be a reference, value given in /home/joomla789/domains/jewishtimesasia.org/public_html/libraries/joomla/cache/handler/callback.php on line 99
Jewish Times Asia is published by Jewish Times Asia Ltd. © Copyright 2019.
Material in the newspaper or on this site may not be used or reproduced in any form or in any way without permission from the editor.
While every effort has been made to ensure the content is true and accurate, the publisher is not responsible for any errors or omissions in the printed text.